Literature DB >> 18316038

Structural polymorphism of two CPP: an important parameter of activity.

Sébastien Deshayes1, Marc Decaffmeyer, Robert Brasseur, Annick Thomas.   

Abstract

Despite numerous investigations, the important structural features of Cell Penetrating Peptides (CPPs) remain unclear as demonstrated by the difficulties encountered in designing new molecules. In this study, we focused our interest on Penetratin and Transportan and several of their variants. Penetratin W48F and Penetratin W48F/W56F exhibit a reduced and a complete lack of cellular uptake, respectively; TP07 and TP10 present a similar cellular uptake as Transportan and TP08, TP13 and TP15 display no or weak internalization capacity. We applied the algorithmic method named PepLook to analyze the peptide polymorphism. The study reveals common conformational characteristics for the CPPs and their permeable variants: they all are polymorphic. Negative, non permeable, mutants share the opposite feature since they are monomorphic. Finally, we support the hypothesis that structural polymorphism may be crucial since it provides peptides with the possibility of adapting their conformation to medium hydrophobicity and or to partner diversity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18316038     DOI: 10.1016/j.bbamem.2008.01.027

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Reversible sheet-turn conformational change of a cell-penetrating peptide in lipid bilayers studied by solid-state NMR.

Authors:  Yongchao Su; Rajeswari Mani; Tim Doherty; Alan J Waring; Mei Hong
Journal:  J Mol Biol       Date:  2008-06-10       Impact factor: 5.469

2.  The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells.

Authors:  Yelee Kim; Hyosuk Kim; Eun Hye Kim; Hochung Jang; Yeongji Jang; Sung-Gil Chi; Yoosoo Yang; Sun Hwa Kim
Journal:  Pharmaceutics       Date:  2022-06-15       Impact factor: 6.525

3.  Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants.

Authors:  Elodie Belnoue; Wilma Di Berardino-Besson; Hubert Gaertner; Susanna Carboni; Isabelle Dunand-Sauthier; Fabrice Cerini; Else-Marit Suso-Inderberg; Sébastien Wälchli; Stéphane König; Andres M Salazar; Oliver Hartley; Pierre-Yves Dietrich; Paul R Walker; Madiha Derouazi
Journal:  Mol Ther       Date:  2016-07-05       Impact factor: 11.454

4.  Folding Then Binding vs Folding Through Binding in Macrocyclic Peptide Inhibitors of Human Pancreatic α-Amylase.

Authors:  Leander Goldbach; Bram J A Vermeulen; Sami Caner; Minglong Liu; Christina Tysoe; Lieke van Gijzel; Ryoji Yoshisada; Mikael Trellet; Hugo van Ingen; Gary D Brayer; Alexandre M J J Bonvin; Seino A K Jongkees
Journal:  ACS Chem Biol       Date:  2019-07-19       Impact factor: 5.100

Review 5.  Cell-Penetrating Peptides: Design Strategies beyond Primary Structure and Amphipathicity.

Authors:  Daniela Kalafatovic; Ernest Giralt
Journal:  Molecules       Date:  2017-11-08       Impact factor: 4.411

6.  Insights into the antibacterial mechanism of PEGylated nano-bacitracin A against Streptococcus pneumonia: both penicillin-sensitive and penicillin-resistant strains.

Authors:  Wei Hong; Lipeng Liu; Zehui Zhang; Yining Zhao; Dexian Zhang; Mingchun Liu
Journal:  Int J Nanomedicine       Date:  2018-10-10

Review 7.  Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents.

Authors:  Antonella Borrelli; Anna Lucia Tornesello; Maria Lina Tornesello; Franco M Buonaguro
Journal:  Molecules       Date:  2018-01-31       Impact factor: 4.411

Review 8.  Cell-Penetrating Peptides and Transportan.

Authors:  Ülo Langel
Journal:  Pharmaceutics       Date:  2021-06-29       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.